first large study of glp 1 receptor agonists during pregnancy Frontiers Research shows GLP-1 receptor agonist
Description
Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system
In 2023, the FDA required the manufacturers of Ozempic and Wegovy to update the drugs warning label to include the risk of bowel obstruction, a severe gastrointestinal side effect
Notably, SCFA-mediated GLP-1 release was abolished in Gpr43 -deficient mice, confirming receptor dependency (Psichas et al., 2015)
Appointments available within days
He and researchers think that changes in blood pressure and blood sugar may be a factor
Diabetes Care 48 , 905913 (2025)
